Table 2.

Characteristics of the Included Randomized Controlled Trials in Children

Study, Year, CountrySetting (n)Mean Age, yInterventionaCo-InterventionBacteriologyMain OutcomesMain ResultsAuthors’ Conclusions
CI=confidence interval; Exp=experimental; GABHS=group A β-hemolytic streptococci, VAS = visual analogue scale.
a All control groups received placebo.
b Median age.
Bulloch et al,11 2003, USAEducational (184)9.710 mg dexamethasone oralAntibiotic: yes if rapid antigen test positive for GABHS
 Analgesic: permitted, not controlledYes10-cm VAS pain score at 24 h Change in pain score at 24 h
 Time until onset of pain relief
 Time to complete pain reliefIf GABHS positive: 5.5 h earlier onset of pain relief (6.0 h vs 11.5 h; P = .02) in the steroid arm“…oral dexamethasone does not decrease the time to onset of clinically significant pain relief or the time to complete pain relief”
Olympia et al,12 2005, USAEducational (125)11.4Maximum 10 mg dexamethasone (0.6 mg/kg) oralAntibiotic: yes if rapid antigen test positive for GABHS
 Analgesic: permitted,YesChange in McGrath Facial Affective scale pain score at 24 h and 48 h
 Time until onset of pain relief
 Time to complete pain reliefIf GABHS positive: 5.1 h (95% CI, 0.5–10.8 h) earlier onset of pain relief (9.7 h vs 14.8 h) in the steroid arm“Immunocompetent children with moderate to severe pharyngitis benefited from the use of oral dexamethasone”
Niland et al,13 2006, USAEducational (84)8bMaximum 10 mg dexamethasone (0.6 mg/kg) oral, 1 or 3 dAntibiotic: yes
 Analgesic: permitted, controlledYesTime until onset of pain relief
 Time improvement of general condition
 Time to improvement of activity level in days1 d earlier onset of pain relief (1 d vs 2 d) in the steroid arm“…children with acute uncomplicated GABHS pharyngitis who receive steroids as add-on treatment are likely to convalesce faster”